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ABSTRACT We have previously demonstrated the ability of electric ﬁelds to dissociate ascorbate and catecholamines and
shown that the electric ﬁeld generated by cell membranes is sufﬁcient to produce dissociation of these complexes up to 8 nm
from the cell membrane. We show here that this process is applicable to a wide range of biological complexes including small
molecules (norepinephrine-morphine sulfate), protein-protein complexes (insulin-glucagon), and small molecule-protein com-
plexes (epinephrine-bovine serum albumin). The extrapolation of the slope of the electric ﬁeld dependence to zero electric ﬁeld
can be used to estimate the log of the dissociation constant (KD) of a complex and, by multiplying the log(KD) by 2.303RT, the
association energy (E) of the complex. The slope of the electric ﬁeld dependence is inversely related to the molecular radii, with
the best ﬁt of the slope related to E*(1/r1 1 1/r2), where r is the estimated radius of each molecule in the complementary pair.
This indicates that the binding site of the pair is shielded by the remaining parts of the molecules, and the larger the molecule
the greater the shielding. When the slope of the electric ﬁeld dependence goes to 0 as r goes to inﬁnity and 1/r goes to 0, the
molecular shielding constant is 7.04 3 108 cm2/V. Very large complexes will be minimally affected by the electric ﬁeld due to
molecular shielding and reduced electric ﬁeld as their radius restricts approach to the membrane. Large protein receptors will
deﬂect the membrane electric ﬁeld and allow agonist binding.
INTRODUCTION
In a previous work we have shown that an electric ﬁeld can
be used to measure the dissociation constant between two
molecules in solution and, further, that the electric ﬁeld pro-
duced by a membrane is more than sufﬁcient to produce dis-
sociation of molecular complexes as they approach within
8 nm of the membrane (1). These ﬁndings were based on
experiments using norepinephrine (NE) and related catechol-
amines binding to ascorbate (Asc) and related compounds.
These ﬁndings left several areas unexplored. First, was this a
general phenomenon, available to affect other small molecule
complexes, complexes of small molecules and proteins, and
protein-protein complexes? Second, what quantitative differ-
ences might appear between complexes having these dif-
ferent compositions? Third, were there general rules that
might be derived based on the interaction of these different
complexes with an electric ﬁeld? Fourth, how would the
membrane electric ﬁeld affect the binding of membrane re-
ceptors to agonists carried into their vicinity by carrier mole-
cules in complex with the agonist?
In testing these questions we ascertained the effect of
electric ﬁelds on the small molecule-small molecule complex
NE-morphine sulfate (MS), the small molecule-protein com-
plex epinephrine-bovine serum albumin (Epi-BSA), and the
protein-protein complex insulin-glucagon (IG). The known
binding of NE and MS (2) may play a role in both the
therapeutic (3) and abusive (4) effects of morphine. The
known binding of Epi to albumin (5) protects Epi from
oxidation and enzymatic degradation as it passes through the
circulatory system. Yet, there still must be dissociation of the
complex for Epi to have its hormonal effects. The data show
that for the measured dissociation constant of NE-Asc
binding, a signiﬁcant fraction of NE will circulate bound to
Asc (1). In contrast, it has been shown that insulin and
glucagon can bind to one another (6) but with a dissociation
constant determined here that is well above both their
physiological concentrations. Thus, although this is a useful
model system for measuring protein-protein binding, it can
also preclude the binding of insulin and glucagon under
physiological conditions.
The positive results of the experiments using these com-
plexes allowed us to make several unique conclusions. These
include the quantitative expression of the molecular shielding
constant, the degree to which a molecular complex shields its
binding sites from an electric ﬁeld based on the association
energy of the complex and the molecular radius of the com-
plex components. Also, having ascertained the behavior of
different sized molecules in the electric ﬁeld, we were able to
conclude that complexes of very large proteins have such a
large amount of shielding and limited approach to the mem-
brane that they are not substantially affected by themembrane
electric ﬁeld. The consequences of our results are discussed
below.
METHODS
The methods employed in measuring the dissociations of NE-Asc, IG,
NE-MS, and Epi-BSA have been described previously for NE-Asc (1).
Solutions
All solutions were prepared in the buffer which was used in the particular
capillary electrophoresis (CE) experiment, 25 mM sodium borate 10-hydrate
(Na2B4O710 H2O) at pH 9.4. NE, Asc, MS, Epi, BSA, insulin, and
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glucagon were purchased from Sigma-Aldrich Chem. Co. (St Louis, MO).
The BSA is Sigma A7409, Initial Fractionation by Heat Shock, 35% in
0.85% sodium chloride. All chemicals were made as stock solutions and
diluted to the required concentration in the CE injection vials. The NE-Asc
dissociation constants were determined using 1 mM NE and altering the
concentration of Asc between 0 and 100 mM. The NE-MS dissociation
constants were determined using 1 mM NE at 204 and 255 V/cm and 0.1
mM at 153 V/cm and altering the concentration of MS between 0 and 40
mM. The IG dissociation constants were determined using a constant
concentration of 20 mM glucagon and altering the concentration of insulin
between 0 and 1.6 mM. The reciprocity of the IG binding was demonstrated
using 20 mM insulin and 0, 19, and 190 mM glucagon. The Epi-BSA
dissociation constants were determined using a constant concentration of 40
mM Epi and altering the concentration of BSA between 0 and 2.32 mM.
CE procedures
Samples were vacuum injected into a 100-mm diameter, 98-cm length
capillary tube (volume 7.7ml) for 2 s (injection volume 8.6 nl/s). The capillary
tube had a detection window 66 cm from the injection site in an ISCO
(Lincoln, NE) model 3850 electropherograph with an absorbance detector at
195 nm, absorbance maximum from 0.02–0.2 absorbance units, and a rise
time of 3.2 s. The driving voltage was varied between 5 and 25 kV, cor-
responding to electric ﬁelds of 51 and 255 V/cm. The peaks were recorded
on a chart recorder (The Recorder Company, Houston, TX) at 1 cm/min and
1 V full scale.
Molecular radius
Estimates of molecular radius are based on the model of the NE-Asc com-
plex (7) and the CPK molecular model system (8) of 1.25 cm/A˚. For the 345
g/mol NE-Asc complex, the complex volume is estimated to be 0.63 nm3.
The relationship between molecular weight (MW) and volume is therefore
0.00183 (MW) ¼ nm3. For a sphere of volume 4pr3/3, this corresponds to a
radius of 0.53 nm for the NE-Asc complex. The radii for the other molecules
and complexes are calculated in the same way.
Data analysis
The constant molecule (NE, Epi, or glucagon) was always prepared and run
as a standard. For each complex, the initial electric ﬁeld dependent dis-
sociation constant was calculated by plotting the log of the varied molecule
concentration against the log of the constant-varied complex/free constant
ratio and applying a least-squares best ﬁt for the linearization and 95%
conﬁdence interval using the Axum data processing system. The initial
dissociation constant at a particular electric ﬁeld, the KE, was estimated from
the linearization at the 0.5 complex-0.5 free point. The initial KE ¼ [free
constant][free varied]/[constant-varied complex]. The [free constant] equals
the [constant-varied complex] at the KE. Thus, the true KE is the [free
varied], which is equal to the [total varied] – 0.5[total constant], and this was
the value used for the KE. The estimate of the dissociation constant at zero
electric ﬁeld, the KD, was made by extrapolating the log of the KE values at
a given electric ﬁeld to zero electric ﬁeld. The binding energy of the
complexes was calculated by multiplying the log(KD) by 2.303RT for the
determination of J/mol at 298 K.
Membrane dissociation
The membrane potential of a membrane decreases exponentially with a
Debye-Hu¨ckel length constant of 1 nm and a voltage change of 30 mV
(9–11). The electric ﬁeld is the length derivative of the voltage decay
(10,11). Having ascertained the relationship of slope (s) (converting V/cm
into mV/nm) and KD between electric ﬁeld and dissociation constants for
a complex pair, the dissociation constant at a given distance (x) from
a membrane with a change in voltage (V0) and a length constant (l) (1) is
logðKEÞx ¼ sð1=lÞV0expðx=lÞ  logðKDÞ:
This equation can be rearranged to calculate the distance at which dif-
ferent changes in KD occur. This is done in Table 1 for 10-, 100-, and 1000-
fold changes in the dissociation constant as the four different complexes
approach the membrane.
RESULTS
Fig. 1 shows the electropherograms of NE, Asc, and the
combination of NE and Asc from Dillon et al. (1). Both NE
and Asc run as a single peak, with Asc passing the detection
window later due to its more negative charge/mass ratio than
NE. When present together at pH 9.4, a third peak appears to
the left of the original NE peak position. This peak has been
shown to vary its size relative to the Asc concentration, in-
creasing as the Asc concentration increases, with a concom-
itant decrease in the free NE peak (1). It is a complex of NE
and Asc. At pH 7.4, both the complex and free NE run at the
same time, with the height of the peak changing with the
concentration of Asc. The dissociation constants for the two
pH values are very similar (1). The dissociation constant for
NE-Asc varies with the applied voltage, shown in the lower
panel of Fig. 1. As the voltage increases, an increasing amount
of Asc is needed for the NE-Asc complex to form, coun-
tering the dissociative effects of the electric ﬁeld.
The reciprocal nature of the electric ﬁeld dissociation of
molecular complexes is shown in Fig. 2. Free glucagon and
free insulin appear as single peaks when run alone. When run
together at the same concentration, there is a decrease in the
size of the glucagon peak and an increase in the size of the
insulin peak. A 10-fold increase in the glucagon concentra-
tion produces a larger increase in the size of the insulin peak,
and the 10-fold increase in the insulin concentration produces
a larger decrease in the glucagon peak. The size of the glu-
cagon peak is plotted against the insulin concentration at two
different electric ﬁelds in the lower panel. Note that despite
having a greater range of electric ﬁelds than the NE-Asc peak
titration curves in Fig. 1, the IG curves are much closer to-
gether. The electric ﬁeld has a smaller effect on the disso-
ciation of IG than it had on NE-Asc.
Electropherograms and individual dissociation curves for
NE-MS and Epi-BSA are shown in Figs. 3 and 4. In the NE-
MS titration in Fig. 3, the NE peak decreases as the MS
TABLE 1 Membrane dissociation of molecular complexes
Radius
nm
Increased dissociation distance (nm)
Complex 10-fold 100-fold 1000-fold
NE-Asc 0.53 8.37 7.68 7.28
NE-MS 0.71 8.53 7.83 7.43
Ins-Glu 2.15 6.89 6.20 5.79
Epi-BSA 2.97 7.29 6.60 6.19
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increases. The effect of NE on MS can also be seen by
comparing the rightmost peak of the MS triplet at zero NE,
on the right of the electropherogram stack, to the same
rightmost peak in the presence of NE. When NE is present,
the rightmost peak is smaller. In Fig. 4, the Epi decreases in
height and broadens as the concentration of BSA increases. It
is well known that Epi binds to BSA (5). This CE procedure
allows a novel way to measure the dissociation constant for
that binding.
Fig. 5 shows the calculated KEs for the different paired
complexes at different electric ﬁelds and the linear intercepts
at zero electric ﬁeld, the KDs. The complex pairs having two
small molecules, NE-Asc and NE-MS, have much greater
slopes than those complex pairs with proteins, insulin-
glucagon, and Epi-BSA. Note that the two complexes with
protein and the NE-Asc complex have very similar KDs,
whereas the KD for NE-MS is much lower. The second
ordinate shows the association energy for the complexes.
There are ﬁve binding sites for the NE-Asc complex, four
hydrogen bonds and one p-p bond (7), each with;5 kJ/mol
(12,13). The calculated association energy of 25.2 kJ/mol
from the intercept closely approximates this. Despite the
complex nature of the proteins in the IG and Epi-BSA com-
plexes, the similar dissociation constants can be inferred to
indicate similar binding energies.
It has been shown that the electric ﬁeld generated by a
membrane is sufﬁcient to cause dissociation of molecular
complexes as they approach the membrane (1). Table 1 com-
pares the size of the four molecular complexes and the
distances from the membrane at which there would be 10-,
100-, and 1000-fold increases in the dissociation constant,
leading to easier dissociation. In all cases, the molecular
radius of the complex pair is much less than the distance
from the membrane that produces signiﬁcant changes in the
dissociation constant resulting in enhanced dissociation of
the complex.
As the change in dissociation produced by the membrane
requires that the complex approach the membrane, very large
molecular complexes will not be able to approach the
FIGURE 1 (Top panel) NE-Asc complex formation. Separate injections
of NE and Asc produce single peaks. A new peak appears when they are
mixed and injected together. The * indicates free NE. (Bottom panel)
Electric ﬁeld dependence of NE-Asc binding. Data points and best ﬁt lines
for the titration of 1.0 mM NE by Asc at different electric ﬁelds. At greater
electric ﬁelds, more Asc is needed to saturate NE. The KEs for 102, 128, 153,
179, and 204 V/cm are 1.1, 2.6, 8.3, 14.8, and 32.4 mM, respectively.
FIGURE 2 (Top panel) Electropherograms of insulin and glucagon. The *
indicates the glucagon peak. The1 indicates the insulin peak. When present
together, the molecules bind with a reduction in the glucagon peak and
increase in the insulin peak. (Bottom panel) Titration of 20 mM glucagon
with insulin in electric ﬁelds of 204 and 51 V/cm. The squares indicate the
204 V/cm data and the triangles indicate the 51 V/cm data. The KEs for
51 and 204 V/cm are 95 and 295 mM, respectively. At higher electric
ﬁelds more insulin is needed to bind glucagon to overcome the dissociating
effect of the greater electric ﬁeld.
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membrane sufﬁciently closely to increase dissociation
signiﬁcantly. Fig. 6 shows the log of the complex radius
plotted against the log of the distance necessary for a 10-fold
decrease in the dissociation constant. At the x intercept, the
radius, calculated from the log(radius), will be the largest size
a complex can be and still have a 10-fold change in dissoci-
ation. This size corresponds approximately to an 800,000
MW complex.
Table 2 shows the relation between the different elements
of these experiments and the slope of the electric ﬁeld dis-
sociation. The association energy alone and the total MW
alone of the two molecules of the complex are not good
indicators of the slope. The best ﬁt, with a correlation co-
efﬁcient of 0.90, relates the sum of the inverse of the radius
of each molecule multiplied by the association energy to the
slope.
The molecular shielding constant is calculated in Fig. 7.
The best ﬁt equation in Table 2 has been rearranged, dividing
each side by the association energy, and the four complexes
plotted as a function of their electric ﬁeld dependent slope,
association energies, and inverse radii. It is clear from the
equation that the slope will become zero as 1/r approaches
zero, or as the radius becomes inﬁnite. This is also intuitively
satisfying, as a very large radius will shield the complex bind-
ing sites from the electric ﬁeld. Constraining, therefore, the
line to go through zero (C ¼ 0 in the model), the molecular
shielding constant (the slope in Fig. 7) is 7.043 108 cm2/V.
FIGURE 3 (Top panel) Electropherograms of NE and MS. The * in-
dicates the NE peak. When present together, the molecules bind with a
reduction in the NE peak and a decrease in the rightmost of the three MS
peaks. (Bottom panel) Titration of 1 mM NE with MS in electric ﬁelds of
102 (:), 153 (n), and 204 (¤) V/cm. The KEs for 102, 153, and 204 V/cm
are 0.42, 3.02, and 21.9 mM, respectively.
FIGURE 4 (Top panel) Electropherograms of Epi in the presence of
different concentrations of BSA. There is a progressive decrease in the Epi
height as the BSA increases. (Bottom panel) Titration of Epi with BSA at
153 (n), 204 ()), and 255 (d) V/cm. The KEs for 153, 204, and 255 V/cm
are 302, 550, and 955 mM, respectively.
FIGURE 5 Comparative electric ﬁeld dependence of dissociation con-
stants and association energy of the complementary pairs NE-Asc, NE-MS,
insulin-glucagon, and Epi-BSA. Their KDs are 39, 8, 68, and 55 mM,
respectively. Different pairs show different electric ﬁeld dependent slopes.
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DISCUSSION
In originally using capillary electrophoresis to measure dis-
sociation constants, all the molecules tested were catechol-
amines and related compounds binding to Asc and related
compounds (1). These experiments were designed to test the
range of molecules over which this method could be used
(Figs. 1–4). NE-MS (2), insulin-glucagon (6), and Epi-BSA
(5) have all been known to form complementary complexes.
These complexes were chosen because they represented
a small molecule-small molecule complex (similar to the
catecholamine-Asc system), a small molecule-protein com-
plex, and a protein-protein complex. All demonstrate that CE
can be used for more than just separating molecules based on
their charge/mass ratio: because CE does not denature
molecules, intermolecular interactions can also be measured.
The multiple examples of molecular coupling show that
the CE method of measuring dissociation constants is
general. When holding one molecule concentration constant,
changes in the concentration of its complementary molecule
result in peak changes to the ﬁrst molecule. CE causes
molecules to separate in an applied electric ﬁeld. If two
molecules are bound at zero electric ﬁeld, and separated at
high electric ﬁeld, there must be an electric ﬁeld at which
they are half-bound and half-free. Further, as the electric ﬁeld
increases, increasing the force of separation, then the con-
centration of complementary molecule needed to maintain
half of the ﬁrst molecule in the complexed form must also
increase. Fig. 5 shows that this is the case for all these
combinations of molecules tested here. Extrapolating to zero
electric ﬁeld deﬁnes the dissociation constant, KD, in free
solution.
The insulin-glucagon and NE-MS electropherograms in
Figs. 2 and 3 show that peak changes can be reciprocal. Just
as insulin causes the glucagon peak to decrease, so too does
glucagon cause the insulin peak to increase. In the case of
NE-MS, however, just as the NE peak decreases with an
increase in MS, the rightmost peak of the MS complex
decreases in the presence of NE. Thus, one cannot make a
priori judgments on the direction a peak change will take
when its complement is present. Molecular coupling would
normally be expected to produce changes in the peak char-
acteristics, although there could be circumstances in which
this does not occur.
We have shown that NE and Asc are connected by four
hydrogen bonds and one p-p interaction (7). Hydrogen
bonds and p-p bonds have similar energy (13). In aqueous
solutions, hydrogen bonds must compete with water
molecules, and hydrogen bonds between nonwater mole-
cules have a strength of 5 kJ/mol (12). The binding energy
we calculate for the NE-Asc binding of 25.2 kJ/mol is con-
sistent with the ﬁve interactions previously shown (7). The
IG and Epi-BSA bindings may have a different number or type
of bonds but produce a similar binding energy. The NE-MS
FIGURE 6 Maximum complex size for 10-fold increase in KD by
membrane electric ﬁeld. As the complex radius increases, the binding site
cannot approach the membrane (distance/radius ¼ 1, log(d/r) ¼ 0). Com-
plexes of large protein pairs (MW 800,000 ;7.0 nm radius) will have
negligible membrane electric ﬁeld dissociation due to highmolecular shielding
and restricted approach to the membrane.
TABLE 2 Models of electric ﬁeld slope dependence on
association energy (E), molecular weight (MW), and
molecular radius (r)
Slope ¼ k 3 1/MWtotal 1 C R2 ¼ 0.60
Slope ¼ k 3 (1/MW1 1 1/MW2) 1 C R2 ¼ 0.63
Slope ¼ k 3 E 1 C R2 ¼ 0.68
Slope ¼ k 3 1/rtotal 1 C R2 ¼ 0.73
Slope ¼ k 3 (1/r1 1 1/r2) 1 C R2 ¼ 0.79
Slope ¼ k 3 (1/r1 1 1/r2) 3 E 1 C R2 ¼ 0.90
FIGURE 7 Calculation of the molecular shielding constant in an electric
ﬁeld (E). The best ﬁt linear model was constrained such that as 1/r ap-
proaches zero (radius goes to inﬁnity), the electric ﬁeld dependent slope (s)
goes to zero as the binding sites are completely shielded from the electric ﬁeld.
The molecular shielding constant is s/E/(1/r11 1/r2)¼ 7.043 108 cm2/V.
1436 Dillon et al.
Biophysical Journal 90(4) 1432–1438
association energy is consistent with having stronger bonds
than the NE-Asc binding. NE-MS binding involves a stronger
p-p bond than NE-Asc, hydrogen bonds and an ionic bond
(2), resulting in a stronger association energy.
Even a cursory analysis of Fig. 5 shows that those com-
plexes containing a protein have much shallower electric
ﬁeld dependence than those with only small molecules.
Since increasing electric ﬁeld strength increases dissociation,
proteins must reduce the amount of dissociation as the elec-
tric ﬁeld increases. This cannot be due to association energy
differences, as the protein association energies are in the
same range as the NE-Asc small molecule pair association
energy. Therefore, qualitatively, increasing the size of mole-
cules must protect their binding sites from the effects of the
electric ﬁeld. The molecular shielding constant provides
a starting point for estimates of the effect of an electric ﬁeld
on a complex. Since the radii for most molecules can be
estimated fairly well, the slope/association energy can be
predicted. The units of the molecular shielding constant,
cm2/V, are also intuitively satisfying. An applied voltage is
spread over an area, and the greater the area the more the
voltage is distributed, lessening its effects. Larger molecules
will have greater areas, lessening the dissociative effects of the
electric ﬁeld.
Given the assumptions made regarding the spherical shapes
of the different molecules and their subunits (insulin is a
dimer (14) and glucagon a trimer (15)), it is remarkable that
this model of the data, using only the radii and association
energies, should give such a good correlation. The radii used
in these calculations are based solely on the MW of the
molecules, assuming a spherical shape. No estimate of the
nonspherical shape of particular molecules or of molecular
complexes was included. That using the simplest assump-
tions produced such robust results leads us to conclude that
although nonspherical shapes may alter the quantitation of
the molecular shielding constant, this alteration will be small,
as will changes in the estimates of the dissociation distance
as a complex approaches the membrane. The spherical as-
sumption may work, in part, because molecules are con-
stantly rotating in the electric ﬁeld. Calculations of the effect
of the electric ﬁeld on the rotational energy of a molecule
show that this effect is minimal, with thermal forces causing
random orientations far exceeding any orientation of the
complex produced by the ﬁeld (16). The change in dipole
orientation equilibrium will be ,1% at 104 V/cm. Thus, any
quantitative effects produced by the nonspherical nature of
a molecule or complex will be minimized by the random-
ization of its orientation within the electric ﬁeld.
Because the membrane potential, in millivolts, exponen-
tially decays over a distance of nanometers in the surround-
ing ﬂuid, the electric ﬁeld near the membrane, in mV/nm, or
104 V/cm, will be much greater than the ﬁeld needed to
produce dissociation, which is in the 102 V/cm range (see
Fig. 5). The exponential decay of the ﬁeld means this ﬁeld
will only exist within 10 nm or less from the membrane. But
within this range, as shown in Table 1, the membrane elec-
tric ﬁeld is more than sufﬁcient to produce dissociation of
molecular complexes. Very large molecular complexes of
proteins may be unable to approach the membrane suff-
iciently close to cause dissociation, as shown in Fig. 6. Large
protein complexes will have both molecular shielding and
limited membrane approach, minimizing the effect of the
electric ﬁeld on these complexes. This will not be the case for
small molecule complexes.
The distance over which the membrane electric ﬁeld could
affect agonist binding covers the range of membrane protein
projection into the interstitial ﬂuid. The electric ﬁeld (E) is
the length derivative of the voltage. As previously cited, the
dielectric constant of water produces a Debye-Hu¨ckel length
constant (l) of 1 nm (9–11) at physiological ionic strength.
The equation governing the determination of the electric
ﬁeld is
E ¼ ð1=lÞVoexpðx=lÞ;
where Vo is the voltage at the membrane and x is the distance
from the membrane. For the extreme electric ﬁelds used in
these experiments, given a membrane voltage of 30 mV, E¼
255 V/cm at 7.07 nm and E ¼ 51 V/cm at 8.68 nm. Given
that the usual distance between adjacent cell membranes is
20 nm, complexes within the extracellular space will always
be exposed to an electric ﬁeld sufﬁcient to alter their binding.
Membrane proteins may project over several nanometers
into the extracellular ﬂuid, having an electric ﬁeld at their
farthest point that could alter binding. For example, the
electric ﬁeld at the far points of 2.7 and 5.9 nm for two
mycobacterial porins (17) are 20,000 and 800 V/cm,
respectively, 6.4 nm (500 V/cm) for the transferrin receptor
(18), and 9.7 nm (18 V/cm, and therefore a much lower
electric ﬁeld effect) for the insulin receptor (19), spanning
the distance where electric ﬁeld dissociation will occur. As
these are proteins they will partially shield their immediate
surroundings from the full electric ﬁeld. The effect of the
electric ﬁeld on the binding of an agonist will be a function of
both the distance of the binding from the membrane and the
shielding of the binding site by the receptor. In relative
terms, however, mobile complexes of small molecules will
be more affected by the electric ﬁeld of the membrane than
will an agonist-receptor complex, with the large radius of the
receptor providing preferred binding of the agonist to the
receptor over that of the agonist to the carrier molecule.
Further, the ﬁxed orientation of the receptor relative to the
electric ﬁeld of the membrane should provide even more
molecular shielding than the average molecule shielding
provided by a complex in solution able to have unrestricted
orientations relative to the membrane electric ﬁeld. As com-
plexes containing an agonist approach the membrane, the
ﬁeld may cause dissociation in areas adjacent to the receptor
to a greater degree than at the receptor itself. This may
produce a gradient of the free agonist toward the receptor,
where the agonist can now bind. Thus molecules like Epi can
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circulate in the blood bound to albumin or Asc, preventing
oxidation. They then diffuse into the interstitial ﬂuid still
bound to Asc (but not albumin, which cannot pass through
a capillary pore) and dissociate as they near a membrane,
available now to bind to a receptor. Based on the broad range
of different molecular pairs presented here, this appears to be
a general phenomenon.
This phenomenon will not be limited to the interstitial
space. The electric ﬁeld will also be signiﬁcant for several
nanometers on the intracellular side of the membrane, where
the electric ﬁeld will mirror the electric ﬁeld on the outside of
the membrane (20). So too, molecular complexes circulating
in the plasma, such as Epi-BSA, will dissociate as they near
the capillary membrane. Other factors not addressed here
experimentally should also be considered. The glycocalyx
extends the membrane potential by several nanometers on
the outside (but not the inside) of the cell membrane (21).
The membrane potential has its greatest change (and largest
electric ﬁeld) just beyond the glycocalyx. Thus, in cells with
a large glycocalyx, the effect of the electric ﬁeld on agonist
binding will have this additional factor. This will be a further
consideration when considering the degree to which the
water shell around an ion such as Na1 is stripped by the
electric ﬁeld as it approaches an ion channel. If the extent of
the pore is within the range of the glycocalyx, the stripping
effect of the electric ﬁeld will be reduced.
It may be possible to apply electric dissociation in a speciﬁc
manner for practical purposes such as drug delivery. Bonds
with energies in this range absorb energy in the infrared
spectrum (13). Capillary electrophoresis uses DC voltage to
effect dissociation. Within the DC ﬁeld are all the AC
frequencies with wavelengths shorter than the length of the
DC ﬁeld, in this case 98 cm. The power input in our system for
the 204 V/cm ﬁeld is 1.58 J/s. Application of one or several
frequencies speciﬁc to the complementary pair will split the
pair with a lower total energy input. Differences in the number
of H-bonds, p-p bonds, and frequency differences produced
by bond stretching (13) may produce unique frequency pat-
terns that allow selective dissociation of a speciﬁc complex,
if these frequencies can be determined and applied. Thus, it
should be possible to separate molecular complexes with
much lower energy input than using conventional CE. If these
frequencies can penetrate skin sufﬁciently, they can be used to
dissociate complexes in situ.
In summary, capillary electrophoresis can be used to
measure the dissociation constants of many complementary
pairs; the large size of proteins will reduce the effect of the
electric ﬁeld on the dissociation of bound molecules; mem-
brane electric ﬁelds will cause dissociation of all complexes
except the largest protein-protein complexes within 10 nm of
the membrane; and agonists can be delivered to membrane
receptor sites bound to carrier molecules and dissociate in the
vicinity of the receptor.
This work was funded in part by a grant from Acorn Technologies.
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